As of 2024-12-14, the Relative Valuation of Basilea Pharmaceutica AG (BSLN.SW) is 4.99 CHF. This relative valuation is based on P/E multiples. With the latest stock price at 40.30 CHF, the upside of Basilea Pharmaceutica AG based on Relative Valuation is -87.6%.
The range of the Relative Valuation is (0.42) - 15.07 CHF.
| Range | Selected | |
| Trailing P/E multiples | 7.9x - 14.6x | 11.2x |
| Forward P/E multiples | 7.9x - 19.5x | 13.7x |
| Fair Price | (0.42) - 15.07 | 4.99 |
| Upside | -101.1% - -62.6% | -87.6% |
| Date | P/E |
| 2024-12-13 | -749.21 |
| 2024-12-12 | -755.72 |
| 2024-12-11 | -764.08 |
| 2024-12-10 | -765.94 |
| 2024-12-09 | -753.86 |
| 2024-12-06 | -748.28 |
| 2024-12-05 | -744.56 |
| 2024-12-04 | -745.49 |
| 2024-12-03 | -760.36 |
| 2024-12-02 | -761.29 |
| 2024-11-29 | -775.24 |
| 2024-11-28 | -769.66 |
| 2024-11-27 | -759.43 |
| 2024-11-26 | -754.79 |
| 2024-11-25 | -782.67 |
| 2024-11-22 | -767.80 |
| 2024-11-21 | -753.86 |
| 2024-11-20 | -750.14 |
| 2024-11-19 | -738.98 |
| 2024-11-18 | -739.91 |
| 2024-11-15 | -743.63 |
| 2024-11-14 | -756.65 |
| 2024-11-13 | -762.22 |
| 2024-11-12 | -765.94 |
| 2024-11-11 | -777.10 |
| 2024-11-08 | -784.53 |
| 2024-11-07 | -790.11 |
| 2024-11-06 | -791.97 |
| 2024-11-05 | -801.26 |
| 2024-11-04 | -811.49 |
| 2024-11-01 | -803.12 |
| 2024-10-31 | -795.69 |
| 2024-10-30 | -808.70 |
| 2024-10-29 | -811.49 |
| 2024-10-28 | -828.22 |
| 2024-10-25 | -833.80 |
| 2024-10-24 | -821.71 |
| 2024-10-23 | -830.08 |
| 2024-10-22 | -825.43 |
| 2024-10-21 | -836.59 |
| 2024-10-18 | -847.74 |
| 2024-10-17 | -832.87 |
| 2024-10-16 | -835.66 |
| 2024-10-15 | -841.23 |
| 2024-10-14 | -848.67 |
| 2024-10-11 | -844.02 |
| 2024-10-10 | -839.37 |
| 2024-10-09 | -826.36 |
| 2024-10-08 | -828.22 |
| 2024-10-07 | -837.52 |